20.51
price up icon3.32%   0.66
after-market 시간 외 거래: 20.51
loading

Enliven Therapeutics Inc (ELVN) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
14.33%
25.99
22.73 24.25 20.13 16.42
Operating Income/Loss
14.33%
-25.99
-22.73 -24.25 -20.13 -16.42
Nonoperating Income/Loss
3.27%
3.249
3.359 3.479 3.413 1.694
Income/Loss From Continuing Operations Before Tax
17.39%
-22.74
-19.37 -20.77 -16.72 -14.72
Income/Loss From Continuing Operations After Tax
17.39%
-22.74
-19.37 -20.77 -16.72 -14.72
Net Income/Loss
17.39%
-22.74
-19.37 -20.77 -16.72 -14.72
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,135%
42.05
1.8811 41.03 40.96 18.51
Diluted Average Shares
2,135%
42.05
1.8811 41.03 40.96 18.51
Basic Earnings Per Share
17.39%
-0.54
-0.46 -0.51 -0.41 -0.80
Diluted Earnings Per Share
17.39%
-0.54
-0.46 -0.51 -0.41 -0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.30
price down icon 0.47%
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
자본화:     |  볼륨(24시간):